AV
Advanced Viral Research Corp Stock: price and insider trades · United States
Advanced Viral Research Corp: what insiders have been doing
Insider filings for Advanced Viral Research Corp are scarce in the SEC (Form 4) feed, the latest one published on 29 December 2009. This page will fill in as new trades are disclosed. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
· cache
Last declaration on 29 December 2009
Declarations4 total
- 72,042,086 shares0Common StockSEC:0001209191-09-058885:0
- 58,775,000 shares0Common StockSEC:0001209191-09-058886:0
- 635,593 sharesCommon StockSEC:0001209191-08-002250:0
- 635,593 sharesCommon StockSEC:0001209191-08-002249:0
4 of 4 declarations
About Advanced Viral Research Corp
Advanced Viral Research Corp is a company focused on the research and development of antiviral treatments. It is listed on NASDAQ under the symbol XNAS.
